Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting
Subcutaneous phycomycosis becomes a chronic, debilitating condition if left untreated. Treatment includes oral antifungal therapy, though oral potassium iodide has been used in resource-limited settings. Lugol's iodine has been an effective substitute, but little is known about its safety. We r...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Medical Mycology Case Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S221175392200032X |
_version_ | 1811295695775203328 |
---|---|
author | Dean S. Karahalios Andrea Shaw Bonnke Arunga Carlee Lenehan Valentine Sing'oei Walter Otieno |
author_facet | Dean S. Karahalios Andrea Shaw Bonnke Arunga Carlee Lenehan Valentine Sing'oei Walter Otieno |
author_sort | Dean S. Karahalios |
collection | DOAJ |
description | Subcutaneous phycomycosis becomes a chronic, debilitating condition if left untreated. Treatment includes oral antifungal therapy, though oral potassium iodide has been used in resource-limited settings. Lugol's iodine has been an effective substitute, but little is known about its safety. We report a case of subcutaneous phycomycosis complicated by heart failure during treatment with Lugol's iodine. We review subcutaneous phycomycosis, iodine-mediated cardiotoxicity, as well as social determinants of health relevant to our case, suggesting that Lugol's iodine may only be an effective treatment with proper dosing and long-term monitoring. |
first_indexed | 2024-04-13T05:36:25Z |
format | Article |
id | doaj.art-2403ffbaba8745f7ab3ad61699256c96 |
institution | Directory Open Access Journal |
issn | 2211-7539 |
language | English |
last_indexed | 2024-04-13T05:36:25Z |
publishDate | 2022-12-01 |
publisher | Elsevier |
record_format | Article |
series | Medical Mycology Case Reports |
spelling | doaj.art-2403ffbaba8745f7ab3ad61699256c962022-12-22T03:00:15ZengElsevierMedical Mycology Case Reports2211-75392022-12-0138912Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited settingDean S. Karahalios0Andrea Shaw1Bonnke Arunga2Carlee Lenehan3Valentine Sing'oei4Walter Otieno5SUNY Upstate Medical University Department of Pediatrics, 750 East Adams Street, Syracuse, NY, 13210, USA; Corresponding author. Children's Hospital of Michigan Department of Pediatrics, Division of Pediatric Cardiology, 3901, Beaubien Boulevard, Detroit, MI, 48201, United States.SUNY Upstate Medical University Departments of Medicine, Pediatrics, and International Health, 750 East Adams Street, Syracuse, NY, 13210, USAObama Children's Hospital, Jomo Kenyatta Highway Kaloleni, Kisumu, KenyaSUNY Upstate Medical University Department of Pediatrics, 750 East Adams Street, Syracuse, NY, 13210, USAObama Children's Hospital, Jomo Kenyatta Highway Kaloleni, Kisumu, KenyaObama Children's Hospital, Jomo Kenyatta Highway Kaloleni, Kisumu, KenyaSubcutaneous phycomycosis becomes a chronic, debilitating condition if left untreated. Treatment includes oral antifungal therapy, though oral potassium iodide has been used in resource-limited settings. Lugol's iodine has been an effective substitute, but little is known about its safety. We report a case of subcutaneous phycomycosis complicated by heart failure during treatment with Lugol's iodine. We review subcutaneous phycomycosis, iodine-mediated cardiotoxicity, as well as social determinants of health relevant to our case, suggesting that Lugol's iodine may only be an effective treatment with proper dosing and long-term monitoring.http://www.sciencedirect.com/science/article/pii/S221175392200032XSubcutaneous phycomycosisFungal infectionLugol's iodineHeart failureSocial determinants of health |
spellingShingle | Dean S. Karahalios Andrea Shaw Bonnke Arunga Carlee Lenehan Valentine Sing'oei Walter Otieno Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting Medical Mycology Case Reports Subcutaneous phycomycosis Fungal infection Lugol's iodine Heart failure Social determinants of health |
title | Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting |
title_full | Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting |
title_fullStr | Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting |
title_full_unstemmed | Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting |
title_short | Adverse effects of Lugol’s iodine: Heart failure in a patient with subcutaneous phycomycosis from a resource-limited setting |
title_sort | adverse effects of lugol s iodine heart failure in a patient with subcutaneous phycomycosis from a resource limited setting |
topic | Subcutaneous phycomycosis Fungal infection Lugol's iodine Heart failure Social determinants of health |
url | http://www.sciencedirect.com/science/article/pii/S221175392200032X |
work_keys_str_mv | AT deanskarahalios adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting AT andreashaw adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting AT bonnkearunga adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting AT carleelenehan adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting AT valentinesingoei adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting AT walterotieno adverseeffectsoflugolsiodineheartfailureinapatientwithsubcutaneousphycomycosisfromaresourcelimitedsetting |